Cell Cycle‐Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer
BioMed Research International · 2023
DOI: 10.1155/2023/1733100 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2023. Verfasst von Jialei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, Ch…. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Head and Neck Neoplasms, Neoplasms, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Laryngeal squamous cell cancer (LSCC) is a common malignant tumor with a high degree of malignancy, and its etiology remains unclear. Therefore, screening potential biomarkers is necessary to facilitate the treatment and diagnosis of LSCC. Robust rank aggregation (RRA) analysis was used to integrate two gene expression datasets of LSCC patients from the Gene Expression Omnibus (GEO) database and identify differentially expressed genes (DEGs) between LSCC and nonneoplastic tissues. A gene coexpression network was constructed using weighted gene correlation network analysis (WGCNA) to explore potential associations between the module genes and clinical features of LSCC. Combining differential gene expression analysis and survival analysis, we screened potential hub genes, including CDK1, SPC24, HOXB7, and SELENBP1. Subsequently, western blotting and immunohistochemistry were used to test the protein levels in clinical specimens to verify our findings. Finally, four candidate diagnostic and prognostic biomarkers (CDK1, SPC24, HOXB7, and SELENBP1) were identified. We propose, for the first time, that SPC24 is a gene that may associate with LSCC malignancy and is a novel therapeutic target. These findings may provide important mechanistic insight of LSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China.
- Department of Pathology and Pathophysiology, Chongqing Medical University, Chongqing, China.
- Molecular Medicine and Cancer Research Center, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
- Department of Pathology, Chongqing Medical University, Chongqing, China.
- Department of Pathology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Bioinformatics, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.
ORCID-Profile: Jialei Chen, Jing Luo, Jing He, Xianyao Jiang, Ning Jiang, Changhong Yang, Shixun Zhong
Förderung
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Luo, J., He, J., Jiang, X., Jiang, N., Yang, C., & Zhong, S. (2023). Cell Cycle‐Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer. BioMed Research International. https://doi.org/10.1155/2023/1733100
Vancouver
Chen J, Luo J, He J, Jiang X, Jiang N, Yang C, et al. Cell Cycle‐Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer. BioMed Research International. 2023. doi:10.1155/2023/1733100
BibTeX
@article{Chen2023,
author = {Chen, Jialei and Luo, Jing and He, Jing and Jiang, Xianyao and Jiang, Ning and Yang, Changhong and Zhong, Shixun},
title = {Cell Cycle‐Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer},
journal = {BioMed Research International},
year = {2023},
doi = {10.1155/2023/1733100}
}
EUVIMED